Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Structure-Activity Relationships and Drug Design
Atherosclerosis III: Management
Pharmacogenomics: Identification of New Drug Targets
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Yuliya A Ogai1, Taylor A Banks1, Satyen M Gada1
1Allergy-Immunology-Immunization Service, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD.
No abstract available in PubMed .